Drugs for the treatment of menopausal symptoms
- PMID: 20408747
- DOI: 10.1517/14656561003742962
Drugs for the treatment of menopausal symptoms
Abstract
Importance of the field: Over the last decade, the management of the menopause has attracted extensive public and professional debate and has become one of the most controversial areas in clinical practice.
Areas covered in this review: This review provides an overview of the field, primarily from a clinical practice perspective. However, as we have incorporated in this 'big-picture' snapshot of the field both conventional and complementary approaches to managing the menopause, it is not an exhaustive review of the literature.
What the reader will gain: By reviewing menopausal management from the perspective of practicing clinicians, we hope readers will gain insight into decision making processes appropriate for dealing with symptomatic women.
Take home message: Although most women do not require pharmacotherapy for menopausal symptoms, many are severely affected by estrogen deficiency at and beyond menopause and, for such women, hormone therapy is important if they are to retain an acceptable quality of life. This article considers the drug treatment of the symptomatic postmenopausal woman and the safety issues related to these medications.
Similar articles
-
[Indications critically evaluated: hormone-domain hot flashes].MMW Fortschr Med. 2003 Nov 13;145(46):5-8. MMW Fortschr Med. 2003. PMID: 14699822 German. No abstract available.
-
Climacteric: concept, consequence and care.J Med Assoc Thai. 2002 Jun;85 Suppl 1:S1-15. J Med Assoc Thai. 2002. PMID: 12188398 Review.
-
Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.Climacteric. 2003 May;6 Suppl 1:11-36. Climacteric. 2003. PMID: 12945798 Review.
-
Approach to the patient with menopausal symptoms.J Clin Endocrinol Metab. 2008 Dec;93(12):4567-75. doi: 10.1210/jc.2008-1272. J Clin Endocrinol Metab. 2008. PMID: 19056840
-
Prognostic features of menopausal and postmenopausal applicants for life insurance.J Insur Med. 1996;28(1):27-34. J Insur Med. 1996. PMID: 10172866 Review.
Cited by
-
Sharing Pathological Mechanisms of Insomnia and Osteoporosis, and a New Perspective on Safe Drug Choice.J Menopausal Med. 2018 Dec;24(3):143-149. doi: 10.6118/jmm.2018.24.3.143. Epub 2018 Dec 31. J Menopausal Med. 2018. PMID: 30671405 Free PMC article. Review.
-
Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk.Cancer Lett. 2011 Nov 28;310(2):216-21. doi: 10.1016/j.canlet.2011.07.007. Epub 2011 Jul 12. Cancer Lett. 2011. PMID: 21802839 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials